HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells.

AbstractBACKGROUND:
Osteopontin (OPN) is a secreted glycophosphoprotein that is overexpressed in various tumors, and high levels of OPN have been associated with poor prognosis of cancer patients. In patients with head and neck cancer, high OPN plasma levels have been associated with poor prognosis following radiotherapy. Since little is known about the relationship between OPN expression and radiosensitivity, we investigated the cellular and radiation induced effects of OPN siRNA in human MDA-MB-231 breast cancer cells.
METHODS:
MDA-MB-231 cells were transfected with OPN-specific siRNAs and irradiated after 24 h. To verify the OPN knockdown, we measured the OPN mRNA and protein levels using qRT-PCR and Western blot analysis. Furthermore, the functional effects of OPN siRNAs were studied by assays to assess clonogenic survival, migration and induction of apoptosis.
RESULTS:
Treatment of MDA-MB-231 cells with OPN siRNAs resulted in an 80% decrease in the OPN mRNA level and in a decrease in extracellular OPN protein level. Transfection reduced clonogenic survival to 42% (p = 0.008), decreased the migration rate to 60% (p = 0.15) and increased apoptosis from 0.3% to 1.7% (p = 0.04). Combination of OPN siRNA and irradiation at 2 Gy resulted in a further reduction of clonogenic survival to 27% (p < 0.001), decreased the migration rate to 40% (p = 0.03) and increased apoptosis to 4% (p < 0.005). Furthermore, OPN knockdown caused a weak radiosensitization with an enhancement factor of 1.5 at 6 Gy (p = 0.09) and a dose modifying factor (DMF10) of 1.1.
CONCLUSION:
Our results suggest that an OPN knockdown improves radiobiological effects in MDA-MB-231 cells. Therefore, OPN seems to be an attractive target to improve the effectiveness of radiotherapy.
AuthorsAntje Hahnel, Henri Wichmann, Matthias Kappler, Matthias Kotzsch, Dirk Vordermark, Helge Taubert, Matthias Bache
JournalRadiation oncology (London, England) (Radiat Oncol) Vol. 5 Pg. 82 (Sep 17 2010) ISSN: 1748-717X [Electronic] England
PMID20849637 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Small Interfering
  • Osteopontin
Topics
  • Apoptosis (genetics, radiation effects)
  • Blotting, Western
  • Breast Neoplasms (genetics, metabolism)
  • Cell Line, Tumor
  • Cell Movement (genetics, radiation effects)
  • Female
  • Gene Knockdown Techniques
  • Humans
  • Osteopontin (genetics, metabolism)
  • RNA, Small Interfering
  • Radiation Tolerance (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: